期刊文献+

精氨酸加压素在血管舒张陛休克治疗中的进展 被引量:4

Arginine vasopressin in vasodilatory shock
原文传递
导出
摘要 精氨酸加压素(arginine vasopressin,AVP)是一种强有力的血管收缩药,又称为抗利尿激素,用于治疗血管舒张性休克时,可有效提升血压、增加尿量和减少儿茶酚胺用量。现就AVP在血管舒张性休克中的应用作一综述,对其在改善血液动力学、器官灌注、疾病转归等方面的作用进行评估。 Arginine vasopressin is one of the potent vasoconstrictive agents and it is also called antidiuretic hormone. Its infusion can effectively increase blood pressure and urine output, and can decrease the dose requirement of catecholamine during the treatment of vasodilatory shock. This article reviewed the researches of arginine vasopressin in vasodilatory shock to evaluate the changes in heamodynamics, the perfusion of different organs, and the outcome of disease during the course of its use.
出处 《国际麻醉学与复苏杂志》 CAS 2009年第5期469-472,共4页 International Journal of Anesthesiology and Resuscitation
关键词 精氨酸加压素 休克 血管舒张 血管收缩药 Arginine vasopressin Shock, vasodilation Vasoconstrictor agents
  • 相关文献

参考文献22

  • 1Gessner P. The effects of vasopressin on the renal system in vasodilatory shock. Dimens Crit Care Nurs, 2006, 25(1): 1-8.
  • 2Holmes CL, Patel BM, Russell JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest, 2001, 120(3): 989-1002.
  • 3Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med, 2004, 30(7): 1276-1291.
  • 4Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med, 2007, 35(1): 33-40.
  • 5Russell JA. Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care, 2007,13(4): 383-391.
  • 6Oliver JA, Landry DW. Endogenous and exogenous vasopressin in shock. Curr Opin Crit Care, 2007, 13(4): 376-382.
  • 7Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anes- thesiology, 2002, 96(3): 576-582.
  • 8Krismer AC, Dtinser MW, Lindner KH, et al. Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature. Am J Cardiovasc Drugs, 2006, 6(1): 51-68.
  • 9Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock : a prospective, randomized, controlled study. Circulation, 2003, 107(18): 2313-2319.
  • 10Hall LG, Oyen LJ, Taner CB, et al. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy, 2004, 24(8) : 1002-1012.

同被引文献59

  • 1Jochberger S, Velik-Salchner C, Mayr VD, et al. The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study. Intensive Care Med, 2009, 35(3): 489-497.
  • 2Suojaranta-Ylinen RT, Vento AE, P/itil~i T, et al. Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Scand J Surg, 2007, 96 (4): 314-318.
  • 3Dunser MW, Mayr A J, Ulmer H, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg, 2001, 93(1): 7-13.
  • 4Lechner E, Hofer A, Mair R, et al. Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass. Eur J Pedlatr, 2007, 166(12): 1221-1227.
  • 5Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med, 2007, 35(1): 33-40.
  • 6Krismer AC, Dtinser MW, Lindner KH, et al. Vasopressin during eardiopulmonary resuscitation and different shock states: a review of the literature. Am J Cardiovase Drugs, 2006, 6( 1 ) : 51-68.
  • 7Garcia-Villalon AL, Garcia JL, Fernandez N, et al. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. BrJ Pharmacol, 1996, 118(7): 1848- 1854.
  • 8Memmola C, lliceto S, Rizzon P. Detection of proximal stenosis of left coronary artery by digital transesophageal echocardiography: feasibility, sensitivity, and specificity. J Am Soc Echocardiogr, 1993, 6(2): 149-157.
  • 9Alam M, Gabriel F, Khaja F, et al. Transesophageal echocardiographic evaluation of left main coronary artery. Angiology, 1995, 46(12): 1103-1106.
  • 10Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev, 2001, 81 (2) : 629-683.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部